|
|
INIFY Laboratories AB
OSL •
Healthcare •
Diagnostics & Research •
Quote as of 09/11/2026 16:05
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeOSL
Market Capitalization644.85 mln
Earnings Date10/28/2026
Pre-Tax Margin
-323%
Severely loss-making
Business Description
INIFY Laboratories AB is a Stockholm-based company founded in 2021 that specializes in detecting prostate cancer for patients in Sweden.
Key Fundamentals
EPS-0.83
ROE-51.71
ROIC-97.38
ROA-45.02
EBITDA, mln-71.67
EV / EBITDA-10.46
EV / EBIT-9.45
Revenue, mln24.75
EV / Revenue30.54
Financial Strength
Altman Z-Score18.01
Piotroski F-Score
3
/ 9
Beneish M-Score-2.53
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-9.37% |
5
/ 100
 |
| 1 Month |
-23.18% |
5
/ 100
|
| 2 Months |
47.96% |
96
/ 100
 |
| 6 Months |
52.63% |
93
/ 100
 |
| 1 Year |
-3.33% |
38
/ 100
 |
|
| |
